Kanwal Raj
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kanwal Raj has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Namita Misra
Medicinal and Process Chemistry Division , Central Drug Research Institute , Lucknow, UP, India
3 shared publicationsSatish Kumar
Medicinal & Process Chemistry, CSIR‐Central Drug Research Institute, Lucknow 226001, India
3 shared publicationsAkhilesh Kumar Tamrakar
Division of Biochemistry , Central Drug Research Institute , Lucknow, India
1 shared publication- Amar Bahadur Singh
Department of Veterans Affairs, Palo Alto Health Care System, Palo Alto, CA 94304, USA
1 shared publication Ankita Misra
Pharmacology Division, CSIR‐Central Drug Research Institute, Lucknow 226001, India
1 shared publicationAnoop Kumar Pandey
Department of Physics, Lucknow University, Lucknow 226007, India
1 shared publication
Latest Publications
- 28 March 2013
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 81 (4) , 499-508
Antithrombotic Activity of a Newly Synthesized Coumarin Derivative 3‐(5‐Hydroxy‐2,2‐dimethyl‐chroman‐6‐yl)‐N‐{2‐[3‐(5‐hydroxy‐2,2‐dimethyl‐chroman‐6‐yl)‐propionylamino]‐ethyl}‐propionamide
Anti‐platelet therapy is a useful strategy to prevent acute thromboembolic artery occlusions. This study was designed to assess the efficacy of seselin derivatives against murine pulmonary thromboembolism, bleeding time, platelet activation and thrombosis. Administration of C3 (16 mg/kg) offered 70% protection against collagen‐ and epinephrine‐induced pulmonary thromboembolism and 30% protection against arachidonic acid‐induced death in mice, without adversely affecting bleeding time. No significant difference was observed by C3 in ferric chloride‐induced arterial thrombosis in rats. Significant reduction in thrombus weight was observed in arteriovenous shunt model. In rat PRP, C3 reduced ADP and collagen‐induced platelet aggregation. In chronic hamster model of dyslipidemia, administration of C3 (16 mg/kg p.o. for 90 days) had no effect on plasma lipids, vasoreactivity and platelet adhesion. C3 fed hamsters showed reduced whole‐blood aggregation response to ADP and collagen compared to HC‐fed hamsters. In addition, C3 augmented thrombin time; however, time to occlusion was not increased. These results convincingly demonstrated that C3 is a novel molecule that reduces the risk of thrombosis and alleviates prothrombotic state associated with hyperlipidemia without any adverse effect on bleeding time. The high benefit/risk ratio of this compound makes it a suitable candidate for future valid studies.
- 28 March 2013
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 81 (4) , 499-508
Antithrombotic Activity of a Newly Synthesized Coumarin Derivative 3‐(5‐Hydroxy‐2,2‐dimethyl‐chroman‐6‐yl)‐N‐{2‐[3‐(5‐hydroxy‐2,2‐dimethyl‐chroman‐6‐yl)‐propionylamino]‐ethyl}‐propionamide
Anti‐platelet therapy is a useful strategy to prevent acute thromboembolic artery occlusions. This study was designed to assess the efficacy of seselin derivatives against murine pulmonary thromboembolism, bleeding time, platelet activation and thrombosis. Administration of C3 (16 mg/kg) offered 70% protection against collagen‐ and epinephrine‐induced pulmonary thromboembolism and 30% protection against arachidonic acid‐induced death in mice, without adversely affecting bleeding time. No significant difference was observed by C3 in ferric chloride‐induced arterial thrombosis in rats. Significant reduction in thrombus weight was observed in arteriovenous shunt model. In rat PRP, C3 reduced ADP and collagen‐induced platelet aggregation. In chronic hamster model of dyslipidemia, administration of C3 (16 mg/kg p.o. for 90 days) had no effect on plasma lipids, vasoreactivity and platelet adhesion. C3 fed hamsters showed reduced whole‐blood aggregation response to ADP and collagen compared to HC‐fed hamsters. In addition, C3 augmented thrombin time; however, time to occlusion was not increased. These results convincingly demonstrated that C3 is a novel molecule that reduces the risk of thrombosis and alleviates prothrombotic state associated with hyperlipidemia without any adverse effect on bleeding time. The high benefit/risk ratio of this compound makes it a suitable candidate for future valid studies.
- Open Access
- 3 June 2012
- Published by Wiley in Journal of Spectroscopy
- Vol. 27 (3) , 155-166
Comparative Study of Vibrational Spectra of Two Bioactive Natural Products Lupeol and Lupenone Using MM/QM Method
This work deals with the theoretical study on the molecular structure and vibrational spectra of two well-known natural products: lupeol and lupenone. The spectra were interpreted with the aid of normal mode analysis following full-structure optimization carried out with the hybrid two-level ONIOM (B3LYP/6-31G: PM3) method. A detailed interpretation of the infrared spectra of Lupeol and Lupenone is also reported in the present work. The similarities and differences between the vibrational spectra of the two molecules studied have been highlighted. The scaled theoretical wave numbers are in perfect agreement with the experimental values. The thermodynamic calculations related to the title compounds were also performed at B3LYP/6-31G: PM3 level of theory. Quantum chemical calculations have been carried out to understand the dynamical behavior of the bioactive molecules Lupeol and Lupenone.
- 3 June 2012
- Published by Wiley in Journal of Spectroscopy
- Vol. 27 (3) , 155-166
Open AccessComparative Study of Vibrational Spectra of Two Bioactive Natural Products Lupeol and Lupenone Using MM/QM Method
This work deals with the theoretical study on the molecular structure and vibrational spectra of two well-known natural products: lupeol and lupenone. The spectra were interpreted with the aid of normal mode analysis following full-structure optimization carried out with the hybrid two-level ONIOM (B3LYP/6-31G: PM3) method. A detailed interpretation of the infrared spectra of Lupeol and Lupenone is also reported in the present work. The similarities and differences between the vibrational spectra of the two molecules studied have been highlighted. The scaled theoretical wave numbers are in perfect agreement with the experimental values. The thermodynamic calculations related to the title compounds were also performed at B3LYP/6-31G: PM3 level of theory. Quantum chemical calculations have been carried out to understand the dynamical behavior of the bioactive molecules Lupeol and Lupenone.
- 17 November 2009
- Published by Taylor & Francis in Natural Product Research
- Vol. 23 (18) , 1671-1676
Clausmarin-C: a novel terpenoid coumarin fromClausena pentaphylla
A novel terpenoid coumarin, clausmarin-C (1), has been isolated from Clausena pentaphylla. Its structure has been established by extensive 1D- and 2D-NMR analysis and chemical transformation.
- 17 November 2009
- Published by Taylor & Francis in Natural Product Research
- Vol. 23 (18) , 1671-1676
Clausmarin-C: a novel terpenoid coumarin fromClausena pentaphylla
A novel terpenoid coumarin, clausmarin-C (1), has been isolated from Clausena pentaphylla. Its structure has been established by extensive 1D- and 2D-NMR analysis and chemical transformation.
- 10 January 2009
- Published by Taylor & Francis in Natural Product Research
- Vol. 23 (1) , 60-69
Novel class of hybrid natural products as antidiabetic agents
A number of O-alkylated xanthone, carbazoles and coumarins have been synthesised and screened for their in vitro anti-diabetic activity, such as glucose-6-phosphatase, glycogen phosphorylase and alpha glucosidase inhibitors. Compounds which were showing significant percentage inhibition were also tested for in vivo anti-hyperglycemic activity in sucrose loaded normal and streptozotocin (STZ)-induced diabetic rats. These compounds show 22.1, 24.4 and 26.7% and 20.8, 25.0, 20.5% lowering in sucrose loaded normal rats and STZ-induced diabetic rats at a dose of 100 mg kg−1.
- 10 January 2009
- Published by Taylor & Francis in Natural Product Research
- Vol. 23 (1) , 60-69
Novel class of hybrid natural products as antidiabetic agents
A number of O-alkylated xanthone, carbazoles and coumarins have been synthesised and screened for their in vitro anti-diabetic activity, such as glucose-6-phosphatase, glycogen phosphorylase and alpha glucosidase inhibitors. Compounds which were showing significant percentage inhibition were also tested for in vivo anti-hyperglycemic activity in sucrose loaded normal and streptozotocin (STZ)-induced diabetic rats. These compounds show 22.1, 24.4 and 26.7% and 20.8, 25.0, 20.5% lowering in sucrose loaded normal rats and STZ-induced diabetic rats at a dose of 100 mg kg−1.
- 10 March 2008
- Published by Taylor & Francis in Natural Product Research
- Vol. 22 (4) , 305-319
Novel class of hybrid natural products derived from lupeol as antimalarial agents
Thirty-four novel hybrid lupeol derivatives (4–18) were prepared and evaluated for antimalarial activity in vitro against Plasmodium falciparum. Three compounds (13d, 16a and 17a) have shown antimalarial activity at lower dose (10 µg mL−1) than lupeol.
- 10 March 2008
- Published by Taylor & Francis in Natural Product Research
- Vol. 22 (4) , 305-319
Novel class of hybrid natural products derived from lupeol as antimalarial agents
Thirty-four novel hybrid lupeol derivatives (4–18) were prepared and evaluated for antimalarial activity in vitro against Plasmodium falciparum. Three compounds (13d, 16a and 17a) have shown antimalarial activity at lower dose (10 µg mL−1) than lupeol.
- 1 October 2006
- Published by Taylor & Francis in Natural Product Research
- Vol. 20 (12) , 1053-1058
Oxidation studies on Andrographolide
Jones oxidation of Andrographolide (1), gave mixture of three products (3-dehydroandrographolide (5), 3,19-bis dehydroandrographolide (6) and 19-dehydroandrographolide (7). Tritylation of andrographolide at C19–OH resulted to products 8 and diene 9, which can be converted to its acetate 10 and oxidation product 11.
- 1 October 2006
- Published by Taylor & Francis in Natural Product Research
- Vol. 20 (12) , 1053-1058
Oxidation studies on Andrographolide
Jones oxidation of Andrographolide (1), gave mixture of three products (3-dehydroandrographolide (5), 3,19-bis dehydroandrographolide (6) and 19-dehydroandrographolide (7). Tritylation of andrographolide at C19–OH resulted to products 8 and diene 9, which can be converted to its acetate 10 and oxidation product 11.